financetom
Business
financetom
/
Business
/
BRIEF-Couche-Tard Sets Up Japan Entity Eyeing Seven & i Takeover Deal - Nikkei Asia
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Couche-Tard Sets Up Japan Entity Eyeing Seven & i Takeover Deal - Nikkei Asia
Feb 28, 2025 2:37 AM

Feb 28 (Reuters) -

* COUCHE-TARD SETS UP JAPAN ENTITY EYEING SEVEN & I TAKEOVER

DEAL

- NIKKEI ASIA

Source text: https://tinyurl.com/bdm8phht

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Abercrombie & Fitch Q2 Momentum Seen Supporting Q2 EPS Beat, Guidance Boost, UBS Says
Abercrombie & Fitch Q2 Momentum Seen Supporting Q2 EPS Beat, Guidance Boost, UBS Says
Aug 15, 2024
03:15 PM EDT, 08/15/2024 (MT Newswires) -- Abercrombie & Fitch's ( ANF ) Q2 sales momentum may lead earnings per share to top estimates by 16 cents and spur a boost in 2024 guidance, UBS Securities said Thursday in a report. Wall Street is already modeling 2024 EPS above the company's implied outlook, likely limiting the extent of upward revisions...
Helmerich & Payne Secures $400 Million Term Loan, Extends Revolver
Helmerich & Payne Secures $400 Million Term Loan, Extends Revolver
Aug 15, 2024
03:10 PM EDT, 08/15/2024 (MT Newswires) -- Helmerich & Payne (HP) said Thursday it secured a $400 million term loan facility. The loan will help finance the company's $1.97 billion acquisition of drilling firm KCA Deutag International. Meanwhile, the company said its lenders agreed to raise the upper limit of its revolving credit facility to $950 million from $750 million...
Lykos to cut 75% of its workforce after FDA setback for MDMA-based PTSD drug
Lykos to cut 75% of its workforce after FDA setback for MDMA-based PTSD drug
Aug 15, 2024
Aug 15 (Reuters) - Lykos Therapeutics said on Thursday it would reduce its workforce by 75% and initiate some executive changes, days after the U.S. Food and Drug Administration declined approval for its MDMA-based treatment for post-traumatic stress disorder. Lykos, formerly known as MAPS Public Benefit Corp, said its founder Rick Doblin was leaving the company's board. It said it...
US State Dept OKs potential $5 bln sale of Patriot missiles to Germany
US State Dept OKs potential $5 bln sale of Patriot missiles to Germany
Aug 15, 2024
WASHINGTON, Aug 15 (Reuters) - The U.S. State Department has approved the possible sale of up to 600 Patriot missiles to Germany for an estimated cost of $5 billion, the Pentagon said on Thursday. The prime contractor will be Lockheed Martin ( LMT ), the Pentagon said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved